Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22565002

Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2012 Aug 1
First author
Bachelot T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2012 Aug 1;30(22):2707-9. doi: 10.1200/JCO.2012.42.1271.
    note
    Source null
    related pmid
    22753913
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2013 Feb 1;31(4):510-1. doi: 10.1200/JCO.2012.46.0980.
    note
    Source null
    related pmid
    23269994
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2013 Feb 1;31(4):511. doi: 10.1200/JCO.2012.46.7399.
    note
    Source null
    related pmid
    23472262
    relationship
    Comment in

Authors and identifiers

  1. name
    Bachelot T
    type
    Author
  2. name
    Bourgier C
    type
    Author
  3. name
    Cropet C
    type
    Author
  4. name
    Ray-Coquard I
    type
    Author
  5. name
    Ferrero JM
    type
    Author
  6. name
    Freyer G
    type
    Author
  7. name
    Abadie-Lacourtoisie S
    type
    Author
  8. name
    Eymard JC
    type
    Author
  9. name
    Debled M
    type
    Author
  10. name
    Spaëth D
    type
    Author
  11. name
    Legouffe E
    type
    Author
  12. name
    Allouache D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bachelot T
    type
    Author
  2. name
    Bourgier C
    type
    Author
  3. name
    Cropet C
    type
    Author
  4. name
    Ray-Coquard I
    type
    Author
  5. name
    Ferrero JM
    type
    Author
  6. name
    Freyer G
    type
    Author
  7. name
    Abadie-Lacourtoisie S
    type
    Author
  8. name
    Eymard JC
    type
    Author
  9. name
    Debled M
    type
    Author
  10. name
    Spaëth D
    type
    Author
  11. name
    Legouffe E
    type
    Author
  12. name
    Allouache D
    type
    Author
bibliography ids
  1. nci-bib-336589a20e223f0f6878fb6e
book metadata
content sha256
a15c6c635f921ced9085f7f4069877f127c0e9e0ab990369a2217a9ae97e8ff3
document type
citation
dois
  1. 10.1200/JCO.2011.39.0708
electronic publication date
display
2012 May 7
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22565002
immutable id
pubmed:22565002@a15c6c635f921ced9085f7f4069877f127c0e9e0ab990369a2217a9ae97e8ff3
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
22
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2718-24
volume
30
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2012 Aug 1;30(22):2707-9. doi: 10.1200/JCO.2012.42.1271.
    note
    Source null
    related pmid
    22753913
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2013 Feb 1;31(4):510-1. doi: 10.1200/JCO.2012.46.0980.
    note
    Source null
    related pmid
    23269994
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2013 Feb 1;31(4):511. doi: 10.1200/JCO.2012.46.7399.
    note
    Source null
    related pmid
    23472262
    relationship
    Comment in
outcomes validated
false
pmid
22565002
provenance
batch id
c95be1d0b8cf19942816
provider
NCBI PubMed ESummary
record sha256
000a74ddce306b40f2f5bcf5e8dcf4c5c5a04ef1dfcbb00b2a2166a2bd5a8f3b
response sha256
a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
retrieved at
2026-09-09T23:46:47.691937+00:00
publication date
display
2012 Aug 1
precision
day
year
2012
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22565002/
title
Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.

Preserved source evidence · Not medical advice